Buy Or Sell Opportunity • Jun 03
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 3.6% to RM0.72. The fair value is estimated to be RM0.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.2% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 23% in a year. Earnings are forecast to grow by 21% in the next year. Declared Dividend • May 29
Dividend reduced to RM0.025 Dividend of RM0.025 is 17% lower than last year. Ex-date: 12th June 2026 Payment date: 30th June 2026 Dividend yield will be 3.7%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is covered by earnings (27% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 11% over the next year, which should provide support to the dividend and adequate earnings cover. Reported Earnings • May 22
First quarter 2026 earnings released: EPS: RM0.011 (vs RM0.017 in 1Q 2025) First quarter 2026 results: EPS: RM0.011 (down from RM0.017 in 1Q 2025). Revenue: RM37.7m (down 18% from 1Q 2025). Net income: RM3.61m (down 36% from 1Q 2025). Profit margin: 9.6% (down from 12% in 1Q 2025). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • May 15
Now 21% overvalued The stock has been flat over the last 90 days, currently trading at RM0.72. The fair value is estimated to be RM0.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.6% over the last 3 years. Earnings per share has grown by 7.8%. Revenue is forecast to grow by 20% in 2 years. Earnings are forecast to grow by 16% in the next 2 years. Board Change • May 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 3 highly experienced directors. Independent Non-Executive Director Norazkha Binti Dahlan was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Apr 30
Hil Industries Berhad, Annual General Meeting, Jun 04, 2026 Hil Industries Berhad, Annual General Meeting, Jun 04, 2026, at 11:00 Singapore Standard Time. Location: bukit kemuning golf & country resort, lot 6031, batu 7, bukit kemuning, 42450 shah alam, selangor darul ehsan, Malaysia Buy Or Sell Opportunity • Apr 23
Now 22% overvalued Over the last 90 days, the stock has fallen 8.1% to RM0.68. The fair value is estimated to be RM0.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.6% over the last 3 years. Earnings per share has grown by 7.8%. Revenue is forecast to grow by 20% in 2 years. Earnings are forecast to grow by 16% in the next 2 years. Reported Earnings • Mar 01
Full year 2025 earnings released: EPS: RM0.097 (vs RM0.12 in FY 2024) Full year 2025 results: EPS: RM0.097 (down from RM0.12 in FY 2024). Revenue: RM219.0m (flat on FY 2024). Net income: RM32.3m (down 22% from FY 2024). Profit margin: 15% (down from 19% in FY 2024). Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 3.9% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Major Estimate Revision • Dec 03
Consensus revenue estimates increase by 33%, EPS downgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from RM162.4m to RM216.3m. EPS estimate fell from RM0.096 to RM0.094. Net income forecast to grow 7.9% next year vs 19% growth forecast for Chemicals industry in Malaysia. Consensus price target down from RM0.80 to RM0.74. Share price was steady at RM0.71 over the past week. Reported Earnings • Nov 27
Third quarter 2025 earnings released: EPS: RM0.018 (vs RM0.029 in 3Q 2024) Third quarter 2025 results: EPS: RM0.018 (down from RM0.029 in 3Q 2024). Revenue: RM63.5m (up 40% from 3Q 2024). Net income: RM5.90m (down 39% from 3Q 2024). Profit margin: 9.3% (down from 21% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 2 years, compared to a 5.0% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 28
Second quarter 2025 earnings released: EPS: RM0.026 (vs RM0.036 in 2Q 2024) Second quarter 2025 results: EPS: RM0.026 (down from RM0.036 in 2Q 2024). Revenue: RM47.1m (down 24% from 2Q 2024). Net income: RM8.47m (down 30% from 2Q 2024). Profit margin: 18% (down from 19% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 5.5% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Malaysia are expected to grow by 4.8%. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Upcoming Dividend • Jun 15
Upcoming dividend of RM0.03 per share Eligible shareholders must have bought the stock before 19 June 2025. Payment date: 03 July 2025. Payout ratio is a comfortable 27% but the company is not cash flow positive. Trailing yield: 4.0%. Lower than top quartile of Malaysian dividend payers (5.6%). Higher than average of industry peers (3.5%). Major Estimate Revision • Jun 04
Consensus revenue estimates fall by 34% The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from RM244.8m to RM162.4m. EPS estimate fell from RM0.139 to RM0.096 per share. Net income forecast to shrink 12% next year vs 30% growth forecast for Chemicals industry in Malaysia . Consensus price target down from RM1.00 to RM0.80. Share price fell 3.8% to RM0.76 over the past week. Declared Dividend • May 31
Dividend of RM0.03 announced Dividend of RM0.03 is the same as last year. Ex-date: 19th June 2025 Payment date: 3rd July 2025 Dividend yield will be 3.9%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is covered by earnings (27% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 9.1% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 7.5% over the next year. However, it would need to fall by 70% to increase the payout ratio to a potentially unsustainable range. Reported Earnings • May 29
First quarter 2025 earnings released: EPS: RM0.017 (vs RM0.032 in 1Q 2024) First quarter 2025 results: EPS: RM0.017 (down from RM0.032 in 1Q 2024). Revenue: RM45.9m (down 27% from 1Q 2024). Net income: RM5.61m (down 47% from 1Q 2024). Profit margin: 12% (down from 17% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 9.9% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Malaysia are expected to grow by 3.7%. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Announcement • Apr 30
Hil Industries Berhad, Annual General Meeting, May 29, 2025 Hil Industries Berhad, Annual General Meeting, May 29, 2025, at 11:00 Singapore Standard Time. Location: bukit kemuning golf & country resort, lot 6031, batu 7, bukit kemuning, 42450 shah alam, selangor darul ehsan, Malaysia Reported Earnings • Apr 20
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: RM0.12 (up from RM0.12 in FY 2023). Revenue: RM219.7m (up 3.6% from FY 2023). Net income: RM40.3m (up 4.3% from FY 2023). Profit margin: 18% (in line with FY 2023). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 4.0% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Announcement • Apr 08
Hil Industries Berhad Approves Single-Tier Final Dividend for Financial Year Ended 31 December 2024 Hil Industries Berhad approved and declared a single-tier final dividend of 3.0 sen per ordinary share in respect of the financial year ended 31 December 2024. Price Target Changed • Mar 01
Price target decreased by 9.1% to RM1.00 Down from RM1.10, the current price target is provided by 1 analyst. New target price is 22% above last closing price of RM0.82. Stock is down 10% over the past year. The company is forecast to post earnings per share of RM0.14 for next year compared to RM0.12 last year. Reported Earnings • Feb 28
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: RM0.12 (up from RM0.12 in FY 2023). Revenue: RM219.7m (up 3.6% from FY 2023). Net income: RM40.3m (up 4.3% from FY 2023). Profit margin: 18% (in line with FY 2023). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 27
Third quarter 2024 earnings released: EPS: RM0.029 (vs RM0.033 in 3Q 2023) Third quarter 2024 results: EPS: RM0.029 (down from RM0.033 in 3Q 2023). Revenue: RM45.5m (down 23% from 3Q 2023). Net income: RM9.66m (down 11% from 3Q 2023). Profit margin: 21% (up from 18% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: RM0.036 (vs RM0.03 in 2Q 2023) Second quarter 2024 results: EPS: RM0.036 (up from RM0.03 in 2Q 2023). Revenue: RM62.2m (up 27% from 2Q 2023). Net income: RM12.1m (up 20% from 2Q 2023). Profit margin: 19% (down from 21% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.8% p.a. on average during the next 2 years, compared to a 6.1% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 04
First quarter 2024 earnings released: EPS: RM0.032 (vs RM0.022 in 1Q 2023) First quarter 2024 results: EPS: RM0.032 (up from RM0.022 in 1Q 2023). Revenue: RM63.1m (up 47% from 1Q 2023). Net income: RM10.5m (up 46% from 1Q 2023). Profit margin: 17% (in line with 1Q 2023). Revenue is forecast to grow 8.2% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 5% per year. Price Target Changed • Jun 04
Price target increased by 21% to RM1.10 Up from RM0.91, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of RM1.13. Stock is up 12% over the past year. The company posted earnings per share of RM0.12 last year. Declared Dividend • Jun 03
Dividend increased to RM0.03 Dividend of RM0.03 is 50% higher than last year. Ex-date: 19th June 2024 Payment date: 28th June 2024 Dividend yield will be 2.7%, which is lower than the industry average of 3.2%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has increased by an average of 9.1% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 20% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to RM1.18, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in Malaysia. Total returns to shareholders of 29% over the past three years. Reported Earnings • Feb 23
Full year 2023 earnings released: EPS: RM0.12 (vs RM0.072 in FY 2022) Full year 2023 results: EPS: RM0.12 (up from RM0.072 in FY 2022). Revenue: RM212.2m (up 25% from FY 2022). Net income: RM38.6m (up 62% from FY 2022). Profit margin: 18% (up from 14% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 2 years, compared to a 5.0% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 24
Third quarter 2023 earnings released: EPS: RM0.033 (vs RM0.022 in 3Q 2022) Third quarter 2023 results: EPS: RM0.033 (up from RM0.022 in 3Q 2022). Revenue: RM58.8m (up 35% from 3Q 2022). Net income: RM10.8m (up 46% from 3Q 2022). Profit margin: 18% (up from 17% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to stay flat during the next 3 years compared to a 3.5% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: RM0.03 (vs RM0.021 in 2Q 2022) Second quarter 2023 results: EPS: RM0.03 (up from RM0.021 in 2Q 2022). Revenue: RM49.1m (up 17% from 2Q 2022). Net income: RM10.1m (up 45% from 2Q 2022). Profit margin: 21% (up from 17% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to stay flat during the next 3 years compared to a 4.4% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year. Upcoming Dividend • Jun 12
Upcoming dividend of RM0.02 per share at 2.0% yield Eligible shareholders must have bought the stock before 19 June 2023. Payment date: 06 July 2023. Payout ratio is a comfortable 27% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of Malaysian dividend payers (5.4%). Lower than average of industry peers (6.1%). Reported Earnings • Jun 03
First quarter 2023 earnings released: EPS: RM0.022 (vs RM0.02 in 1Q 2022) First quarter 2023 results: EPS: RM0.022 (up from RM0.02 in 1Q 2022). Revenue: RM42.8m (up 8.3% from 1Q 2022). Net income: RM7.17m (up 7.6% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth. Board Change • May 02
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Norazkha Binti Dahlan was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 15
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: RM0.072 (down from RM0.091 in FY 2021). Revenue: RM170.3m (flat on FY 2021). Net income: RM24.0m (down 21% from FY 2021). Profit margin: 14% (down from 18% in FY 2021). Revenue missed analyst estimates by 5.0%. Earnings per share (EPS) also missed analyst estimates by 16%. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 3.4% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Mar 01
Full year 2022 earnings released: EPS: RM0.072 (vs RM0.091 in FY 2021) Full year 2022 results: EPS: RM0.072 (down from RM0.091 in FY 2021). Revenue: RM170.3m (flat on FY 2021). Net income: RM24.0m (down 21% from FY 2021). Profit margin: 14% (down from 18% in FY 2021). Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 3.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Feb 28
Price target decreased by 10% to RM0.99 Down from RM1.11, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of RM0.97. Stock is up 4.9% over the past year. The company is forecast to post earnings per share of RM0.088 for next year compared to RM0.091 last year. Reported Earnings • Nov 24
Third quarter 2022 earnings released: EPS: RM0.022 (vs RM0.023 in 3Q 2021) Third quarter 2022 results: EPS: RM0.022 (down from RM0.023 in 3Q 2021). Revenue: RM43.5m (up 17% from 3Q 2021). Net income: RM7.42m (down 2.2% from 3Q 2021). Profit margin: 17% (down from 20% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 27
Investor sentiment improved over the past week After last week's 23% share price gain to RM1.07, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in Malaysia. Total returns to shareholders of 116% over the past three years. Reported Earnings • Aug 26
Second quarter 2022 earnings released: EPS: RM0.021 (vs RM0.013 in 2Q 2021) Second quarter 2022 results: EPS: RM0.021 (up from RM0.013 in 2Q 2021). Revenue: RM42.1m (up 64% from 2Q 2021). Net income: RM6.95m (up 62% from 2Q 2021). Profit margin: 17% (in line with 2Q 2021). Over the next year, revenue is expected to shrink by 4.3% compared to a 6.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Jul 10
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Hun Ooi was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Jun 22
Upcoming dividend of RM0.02 per share Eligible shareholders must have bought the stock before 29 June 2022. Payment date: 15 July 2022. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Malaysian dividend payers (4.9%). Lower than average of industry peers (4.9%). Reported Earnings • Jun 01
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: RM0.02 (up from RM0.019 in 1Q 2021). Revenue: RM39.6m (up 14% from 1Q 2021). Net income: RM6.67m (up 7.4% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Revenue exceeded analyst estimates by 9.9%. Earnings per share (EPS) also surpassed analyst estimates by 26%. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 21% per year. Announcement • May 31
Hil Industries Berhad Announces First and Final Single-Tier Dividend for Financial Year Ended 31 December 2021, Payable on July 15, 2022 Hil Industries Berhad announced first and final single-tier dividend of 2.0 sen per ordinary share in respect of the financial year ended 31 December 2021. Ex-date on June 29, 2022. Payment date on July 15, 2022. Announcement • May 02
Hil Industries Berhad, Annual General Meeting, Jun 28, 2022 Hil Industries Berhad, Annual General Meeting, Jun 28, 2022, at 11:00 Singapore Standard Time. Location: Bukit Kemuning Golf & Country Resort, Lot 6031, Batu 7, Bukit Kemuning, 42450 Shah Alam, Selangor Darul Ehsan SELANGOR DARUL EHSAN Malaysia Agenda: To consider the statement in relation to the proposed renewal of share buy-back authority; to consider the proposed amendments to the constitution of the company; and other subject matters. Announcement • Apr 19
Hil Industries Berhad Declares First and Final Single Tier Dividend in Respect of the Financial Year Ended 31 December 2021 On 18 April 2022, the Board of Directors of Hil Industries Berhad approved and declared a single-tier final dividend of 2.0 sen per ordinary share in respect of the financial year ended 31 December 2021. Reported Earnings • Feb 25
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: RM0.092 (up from RM0.074 in FY 2020). Revenue: RM173.2m (up 6.3% from FY 2020). Net income: RM30.4m (up 24% from FY 2020). Profit margin: 18% (up from 15% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.9%. Earnings per share (EPS) also surpassed analyst estimates by 26%. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 23% per year. Reported Earnings • Nov 26
Third quarter 2021 earnings: EPS and revenues exceed analyst expectations Third quarter 2021 results: EPS: RM0.023 (down from RM0.033 in 3Q 2020). Revenue: RM37.3m (down 24% from 3Q 2020). Net income: RM7.59m (down 30% from 3Q 2020). Profit margin: 20% (down from 22% in 3Q 2020). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 9.9%. Earnings per share (EPS) also surpassed analyst estimates by 26%. Earnings per share (EPS) surpassed analyst estimates by 26%. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 21% per year. Reported Earnings • Sep 15
Second quarter 2021 earnings released: EPS RM0.013 (vs RM0.006 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: RM25.6m (up 17% from 2Q 2020). Net income: RM4.28m (up 99% from 2Q 2020). Profit margin: 17% (up from 9.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 17% per year. Upcoming Dividend • Jul 20
Upcoming dividend of RM0.015 per share Eligible shareholders must have bought the stock before 27 July 2021. Payment date: 18 August 2021. Trailing yield: 1.6%. Lower than top quartile of Malaysian dividend payers (4.1%). Lower than average of industry peers (1.8%). Announcement • May 21
Hil Industries Berhad Declares First and Final Single-Tier Dividend for the Financial Year Ended December 31, 2020, Payable on August 18, 2021 Hil Industries Berhad declared first and final single-tier dividend of 1.50 sen per ordinary share in respect of the financial year ended December 31, 2020, payable on August 18, 2021. Entitlement date is July 28, 2021 and ex-date is July 27, 2021. Reported Earnings • Apr 20
Full year 2020 earnings released: EPS RM0.074 (vs RM0.065 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: RM163.0m (up 5.3% from FY 2019). Net income: RM24.6m (up 14% from FY 2019). Profit margin: 15% (up from 14% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Reported Earnings • Feb 27
Full year 2020 earnings released: EPS RM0.074 (vs RM0.065 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: RM168.2m (up 8.7% from FY 2019). Net income: RM24.6m (up 15% from FY 2019). Profit margin: 15% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Analyst Estimate Surprise Post Earnings • Feb 27
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 9.9%. Earnings per share (EPS) also surpassed analyst estimates by 26%. Over the next year, revenue is forecast to grow 3.5%, compared to a 23% growth forecast for the Chemicals industry in Malaysia. Reported Earnings • Nov 27
Third quarter 2020 earnings released: EPS RM0.033 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: RM49.1m (up 14% from 3Q 2019). Net income: RM10.8m (up 25% from 3Q 2019). Profit margin: 22% (up from 20% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 12% per year. Is New 90 Day High Low • Nov 09
New 90-day high: RM1.10 The company is up 33% from its price of RM0.83 on 11 August 2020. The Malaysian market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Valuation Update With 7 Day Price Move • Oct 22
Market bids up stock over the past week After last week's 16% share price gain to RM1.05, the stock is trading at a trailing P/E ratio of 16.2x, up from the previous P/E ratio of 13.9x. This compares to an average P/E of 19x in the Chemicals industry in Malaysia. Total returns to shareholders over the past three years are 31%. Valuation Update With 7 Day Price Move • Oct 19
Market bids up stock over the past week After last week's 20% share price gain to RM1.04, the stock is trading at a trailing P/E ratio of 16x, up from the previous P/E ratio of 13.3x. This compares to an average P/E of 19x in the Chemicals industry in Malaysia. Total returns to shareholders over the past three years are 33%. Is New 90 Day High Low • Oct 14
New 90-day high: RM0.91 The company is up 62% from its price of RM0.56 on 15 July 2020. The Malaysian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period.